Tag Archives: nivolumab

November, 2018

October, 2018

August, 2018

July, 2018

June, 2018

April, 2018

January, 2018

  • 12 January

    Rare Melanoma Type Highly Responsive to Immunotherapy

    TAMPA, Fla. – Desmoplastic melanoma is a rare subtype of melanoma that is commonly found on sun-exposed areas, such as the head and neck, and usually seen in older patients. Treatment is difficult because these tumors are often resistant to chemotherapy and lack actionable mutations commonly found in other types of …

December, 2017

  • 21 December

    FDA Approves Bristol-Myers’ Opdivo as Adjuvant Therapy in Melanoma Patients

    PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) injection for intravenous use for the adjuvant treatment of patients with melanoma with involvement of lymph nodes or metastatic disease who have undergone complete resection.1 The purpose of adjuvant therapy is to reduce the …